$UPWK
UPWORK, INC Stock $upwk

$upwk Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-Q Financial Statement

#000162747523000033 Filed on May 03, 2023

Income Statement

Concept	2023 Q1
Revenue	$160.9M
YoY Change	13.81%
Cost Of Revenue	$40.43M
YoY Change	6.62%
Gross Profit	$120.4M
YoY Change	16.45%
Gross Profit Margin	74.87%
Selling, General & Admin	$94.29M
YoY Change	8.65%
% of Gross Profit	78.29%
Research & Development	$44.48M
YoY Change	16.56%
% of Gross Profit	36.93%
Depreciation & Amortization	$800.0K
YoY Change	0.0%
% of Gross Profit	0.66%
Operating Expenses	$145.5M
YoY Change	14.48%
Operating Profit	-$25.04M
YoY Change	5.86%
Interest Expense	$1.101M
YoY Change	-2.13%
% of Operating Profit
Other Income/Expense, Net	$44.10M
YoY Change	64754.41%
Pretax Income	$17.96M
YoY Change	-172.69%
Income Tax	$795.0K
% Of Pretax Income	4.43%
Net Earnings	$17.17M
YoY Change	-169.4%
Net Earnings / Revenue	10.67%
Basic Earnings Per Share	$0.13
Diluted Earnings Per Share	-$0.15
COMMON SHARES
Basic Shares Outstanding	132.5M shares
Diluted Shares Outstanding	136.0M shares

Balance Sheet

Concept	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$509.6M
YoY Change	-24.27%
Cash & Equivalents	$102.0M
Short-Term Investments	$407.6M
Other Short-Term Assets	$198.9M
YoY Change	-7.29%
Inventory
Prepaid Expenses
Receivables	$59.29M
Other Receivables	$0.00
Total Short-Term Assets	$767.8M
YoY Change	-19.14%
LONG-TERM ASSETS
Property, Plant & Equipment	$23.10M
YoY Change	10.39%
Goodwill	$118.2M
YoY Change	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$2.120M
YoY Change	27.48%
Total Long-Term Assets	$150.2M
YoY Change	-0.33%
TOTAL ASSETS
Total Short-Term Assets	$767.8M
Total Long-Term Assets	$150.2M
Total Assets	$918.1M
YoY Change	-16.56%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.248M
YoY Change	-58.87%
Accrued Expenses	$47.60M
YoY Change	44.08%
Deferred Revenue	$25.56M
YoY Change	8.53%
Short-Term Debt	$0.00
YoY Change
Long-Term Debt Due	$0.00
YoY Change
Total Short-Term Liabilities	$256.8M
YoY Change	-2.46%
LONG-TERM LIABILITIES
Long-Term Debt	$354.7M
YoY Change	-36.89%
Other Long-Term Liabilities	$7.872M
YoY Change	-22.73%
Total Long-Term Liabilities	$362.6M
YoY Change	-36.64%
TOTAL LIABILITIES
Total Short-Term Liabilities	$256.8M
Total Long-Term Liabilities	$362.6M
Total Liabilities	$629.1M
YoY Change	-26.07%
SHAREHOLDERS EQUITY
Retained Earnings	-$323.8M
YoY Change	17.4%
Common Stock	$613.9M
YoY Change	16.15%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$289.0M
YoY Change
Total Liabilities & Shareholders Equity	$918.1M
YoY Change	-16.56%

Cashflow Statement

Concept	2023 Q1
OPERATING ACTIVITIES
Net Income	$17.17M
YoY Change	-169.4%
Depreciation, Depletion And Amortization	$800.0K
YoY Change	0.0%
Cash From Operating Activities	-$8.701M
YoY Change	-24.18%
INVESTING ACTIVITIES
Capital Expenditures	$158.0K
YoY Change	-18.13%
Acquisitions
YoY Change
Other Investing Activities	$155.0M
YoY Change	-389.08%
Cash From Investing Activities	$152.1M
YoY Change	-376.39%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$152.0M
YoY Change	-521.68%
NET CHANGE
Cash From Operating Activities	-$8.701M
Cash From Investing Activities	$152.1M
Cash From Financing Activities	-$152.0M
Net Change In Cash	-$8.596M
YoY Change	-71.78%
FREE CASH FLOW
Cash From Operating Activities	-$8.701M
Capital Expenditures	$158.0K
Free Cash Flow	-$8.859M
YoY Change	-24.08%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001627475
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021Q3	us-gaap	Debt Conversion Converted Instrument Rate DebtConversionConvertedInstrumentRate	0.015
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-38678
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	UPWORK INC.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-4337682
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	475 Brannan Street, Suite 430
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	San Francisco,
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94107
CY2023Q1	dei	City Area Code CityAreaCode	650
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	316-7500
CY2023Q1	dei	Security12b Title Security12bTitle	Common Stock, $0.0001 par value per share
CY2023Q1	dei	Trading Symbol TradingSymbol	UPWK
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	133464264	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	101985000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	129384000	usd
CY2023Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	407643000	usd
CY2022Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	557230000	usd
CY2023Q1	us-gaap	Escrow Deposit EscrowDeposit	179420000	usd
CY2022Q4	us-gaap	Escrow Deposit EscrowDeposit	161457000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	9018000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	12464000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	59291000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	59291000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	64888000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	64888000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	19481000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	17947000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	767820000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	930906000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	23104000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	22063000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	118219000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	118219000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	6803000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7603000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2120000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1454000	usd
CY2023Q1	us-gaap	Assets Assets	918066000	usd
CY2022Q4	us-gaap	Assets Assets	1080245000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	4248000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	7549000	usd
CY2023Q1	upwk	Escrow Funds Payable EscrowFundsPayable	179420000	usd
CY2022Q4	upwk	Escrow Funds Payable EscrowFundsPayable	161457000	usd
CY2023Q1	upwk	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	47595000	usd
CY2022Q4	upwk	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	53611000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	25557000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	25557000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	25075000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	25075000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	256820000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	247692000	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	354705000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	564261000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	9713000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	11177000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	7872000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	8236000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	629110000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	831366000	usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	490000000	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	490000000	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	133464264	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	133464264	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	132368265	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	132368265	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	13000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	13000	usd
CY2023Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	613887000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	592900000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1162000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3085000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-323782000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-340949000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	288956000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	248879000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	918066000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1080245000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	160858000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	141337000	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	40427000	usd
CY2022Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	37916000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	120431000	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	103421000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	44481000	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	38161000	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	65000000	usd
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	57642000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	29287000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	29141000	usd
CY2023Q1	upwk	Provision For Transaction Losses ProvisionForTransactionLosses	6701000	usd
CY2022Q1	upwk	Provision For Transaction Losses ProvisionForTransactionLosses	2129000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	145469000	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	127073000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-25038000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-23652000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	1101000	usd
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	129359000	shares
CY2022Q1	us-gaap	Interest Expense InterestExpense	1125000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	44101000	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	68000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	17962000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-24709000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	795000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	29000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	17167000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-24738000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.13
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.19
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.15
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.19
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	132836000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	129359000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	135966000	shares
CY2023Q1	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	1923000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-2850000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	19090000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-27588000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	248879000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	758000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	20041000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	188000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	1923000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	17167000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	288956000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	259517000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	488000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	16744000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	188000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-2850000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-24738000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	249349000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	17167000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-24738000	usd
CY2023Q1	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	3712000	usd
CY2022Q1	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	1919000	usd
CY2023Q1	upwk	Depreciation And Amortization Excluding Amortization Of Financing Costs DepreciationAndAmortizationExcludingAmortizationOfFinancingCosts	2024000	usd
CY2022Q1	upwk	Depreciation And Amortization Excluding Amortization Of Financing Costs DepreciationAndAmortizationExcludingAmortizationOfFinancingCosts	2009000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	716000	usd
CY2022Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	740000	usd
CY2023Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	3487000	usd
CY2022Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-537000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	800000	usd
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	751000	usd
CY2023Q1	upwk	Increase Decrease In Common Stock Warrant IncreaseDecreaseInCommonStockWarrant	188000	usd
CY2022Q1	upwk	Increase Decrease In Common Stock Warrant IncreaseDecreaseInCommonStockWarrant	188000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	19900000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	16735000	usd
CY2023Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	38945000	usd
CY2022Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1990000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2990000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1360000	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1394000	usd
CY2023Q1	upwk	Increase Decrease Operating Lease Liability IncreaseDecreaseOperatingLeaseLiability	-1419000	usd
CY2022Q1	upwk	Increase Decrease Operating Lease Liability IncreaseDecreaseOperatingLeaseLiability	-1292000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-3380000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1150000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-6855000	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-12734000	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	248000	usd
CY2022Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	1663000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-8701000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-11476000	usd
CY2023Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	156128000	usd
CY2022Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	160251000	usd
CY2023Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	167416000	usd
CY2022Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	106634000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	143709000	usd
CY2022Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	158000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	193000	usd
CY2023Q1	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	2703000	usd
CY2022Q1	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	1233000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	152136000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-55043000	usd
CY2023Q1	upwk	Changes In Escrow Funds Payable ChangesInEscrowFundsPayable	17963000	usd
CY2022Q1	upwk	Changes In Escrow Funds Payable ChangesInEscrowFundsPayable	35566000	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	758000	usd
CY2022Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	488000	usd
CY2023Q1	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	170752000	usd
CY2022Q1	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	0	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-152031000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	36054000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-8596000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-30465000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	295231000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	352058000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	286635000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	321593000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	811000	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	763000	usd
CY2023Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	79000	usd
CY2022Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	302000	usd
CY2023Q1	us-gaap	Capitalized Costs Asset Retirement Costs CapitalizedCostsAssetRetirementCosts	57000	usd
CY2022Q1	us-gaap	Capitalized Costs Asset Retirement Costs CapitalizedCostsAssetRetirementCosts	0	usd
CY2023Q1	upwk	Marketable Securities Purchases Not Yet Paid MarketableSecuritiesPurchasesNotYetPaid	0	usd
CY2022Q1	upwk	Marketable Securities Purchases Not Yet Paid MarketableSecuritiesPurchasesNotYetPaid	3985000	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:6pt;text-align:justify"><span style="color:#14a800;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make certain estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the periods presented. Such estimates include, but are not limited to: the useful lives of assets; assessment of the recoverability of long-lived assets; goodwill impairment; standalone selling price of material rights and the period of time over which to defer and recognize the consideration allocated to the material rights; allowance for expected credit losses; liabilities relating to transaction losses; stock-based compensation; and accounting for income taxes. Management bases its estimates on historical experience and on various other assumptions that management believes to be reasonable under the circumstances. The Company evaluates its estimates, assumptions, and judgments on an ongoing basis using historical experience and other factors and revises them when facts and circumstances dictate.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is not aware of any specific event or circumstance that would require an update to its estimates or judgments or a revision of the carrying value of its assets or liabilities. These estimates may </span></div>change as new events occur and additional information is obtained. Actual results could differ materially from these estimates under different assumptions or conditions.
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	25075000	usd
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	32900000	usd
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	25600000	usd
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P12M
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	59291000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	59291000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	64888000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	64888000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	25557000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	25557000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	25075000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	7380000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	7614000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	9100000	usd
CY2022Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	7700000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss	510751000	usd
CY2023Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	196000	usd
CY2023Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	1319000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest DebtSecuritiesAvailableForSaleExcludingAccruedInterest	509628000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss	689663000	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	85000	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	3134000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest DebtSecuritiesAvailableForSaleExcludingAccruedInterest	686614000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	46988000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	196000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	80626000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	1123000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	127614000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	1319000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	211052000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	630000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	145460000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	2504000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	356512000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	3134000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	138200000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	101985000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	129384000	usd
CY2023Q1	us-gaap	Restricted Cash RestrictedCash	5230000	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	4390000	usd
CY2023Q1	upwk	Funds Held In Escrow Including Funds In Transit FundsHeldInEscrowIncludingFundsInTransit	179420000	usd
CY2022Q4	upwk	Funds Held In Escrow Including Funds In Transit FundsHeldInEscrowIncludingFundsInTransit	161457000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	286635000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	295231000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	57944000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	54906000	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	34840000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	32843000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	23104000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	22063000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	800000	usd
CY2022Q1	us-gaap	Depreciation Depreciation	800000	usd
CY2023Q1	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	2900000	usd
CY2022Q1	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	1200000	usd
CY2023Q1	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	1200000	usd
CY2022Q1	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	1200000	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	7981000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	17239000	usd
CY2023Q1	upwk	Accrued Freelancer Costs Current AccruedFreelancerCostsCurrent	12042000	usd
CY2022Q4	upwk	Accrued Freelancer Costs Current AccruedFreelancerCostsCurrent	14102000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	15271000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	8858000	usd
CY2023Q1	upwk	Accrued Indirect Taxes Current AccruedIndirectTaxesCurrent	6547000	usd
CY2022Q4	upwk	Accrued Indirect Taxes Current AccruedIndirectTaxesCurrent	6502000	usd
CY2023Q1	upwk	Accrued Payment Processing Fees Current AccruedPaymentProcessingFeesCurrent	2485000	usd
CY2022Q4	upwk	Accrued Payment Processing Fees Current AccruedPaymentProcessingFeesCurrent	2425000	usd
CY2023Q1	upwk	Accrued Vendor Expenses Current AccruedVendorExpensesCurrent	1457000	usd
CY2022Q4	upwk	Accrued Vendor Expenses Current AccruedVendorExpensesCurrent	2352000	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1812000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2133000	usd
CY2023Q1	upwk	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	47595000	usd
CY2022Q4	upwk	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	53611000	usd
CY2023Q1	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	1700000	usd
CY2022Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	800000	usd
CY2022Q4	us-gaap	Line Of Credit LineOfCredit	0	usd
CY2023Q1	us-gaap	Line Of Credit LineOfCredit	0	usd
CY2023Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	360998000	usd
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	575000000	usd
CY2023Q1	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	6293000	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	10739000	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	354705000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	564261000	usd
CY2023Q1	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.0076
CY2022Q4	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.0076
CY2021Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	575000000	usd
CY2021Q3	upwk	Debt Instrument Additional Principal To Be Purchased DebtInstrumentAdditionalPrincipalToBePurchased	75000000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	17167000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-24738000	usd
CY2023Q1	upwk	Gain On Early Extinguishment Of Debt Net Of Tax GainOnEarlyExtinguishmentOfDebtNetOfTax	38525000	usd
CY2022Q1	upwk	Gain On Early Extinguishment Of Debt Net Of Tax GainOnEarlyExtinguishmentOfDebtNetOfTax	0	usd
CY2023Q1	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	389000	usd
CY2022Q1	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	0	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-20969000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-24738000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	132835837	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	129358872	shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	3130578	shares
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	135966415	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	129358872	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.13
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.19
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.15
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.19
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	21297393	shares
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	21244736	shares
CY2023Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2023Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	160858000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	141337000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	160858000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	141337000	usd

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001627475-23-000033-index-headers.html	Edgar Link	pending
0001627475-23-000033-index.html	Edgar Link	pending
0001627475-23-000033.txt	Edgar Link	pending
0001627475-23-000033-xbrl.zip	Edgar Link	pending
exhibit101offerletter.htm	Edgar Link	pending
exhibit102cicagreementgess.htm	Edgar Link	pending
exhibit3111q23.htm	Edgar Link	pending
exhibit3121q23.htm	Edgar Link	pending
exhibit3211q23.htm	Edgar Link	pending
exhibit3221q23.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_0a.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
upwk-20230331.htm	Edgar Link	pending
upwk-20230331.xsd	Edgar Link	pending
upwk-20230331_g1.jpg	Edgar Link	pending
upwk-20230331_def.xml	Edgar Link	unprocessable
upwk-20230331_lab.xml	Edgar Link	unprocessable
upwk-20230331_cal.xml	Edgar Link	unprocessable
upwk-20230331_pre.xml	Edgar Link	unprocessable
upwk-20230331_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$UPWK
UPWORK, INC Stock $upwk

2023 Q1 Form 10-Q Financial Statement

#000162747523000033 Filed on May 03, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$UPWK UPWORK, INC Stock $upwk

2023 Q1 Form 10-Q Financial Statement

#000162747523000033 Filed on May 03, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$UPWK
UPWORK, INC Stock $upwk